Outcomes of Clofazimine vs Rifampicin Use in Patients With Mycobacterium avium Complex Pulmonary Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Chest
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clofazimine is a safe and effective alternative for rifampicin in Mycobacterium avium complex pulmonary disease treatment - outcomes of a randomized trial
Chest 2023 Nov 29;[EPub Ahead of Print], SMH Zweijpfenning, R Aarnoutse, MJ Boeree, C Magis-Escurra, R Stemkens, B Geurts, J van Ingen, W HoefslootFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.